0001144204-16-115995.txt : 20160802 0001144204-16-115995.hdr.sgml : 20160802 20160802165634 ACCESSION NUMBER: 0001144204-16-115995 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160731 FILED AS OF DATE: 20160802 DATE AS OF CHANGE: 20160802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolfenson Barry CENTRAL INDEX KEY: 0001354818 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 161801213 MAIL ADDRESS: STREET 1: DERMA SCIENCES, INC. STREET 2: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 v445796_form4.xml FORM 4 X0306 4 2016-07-31 1 0000892160 DERMA SCIENCES, INC. DSCI 0001354818 Wolfenson Barry DERMA SCIENCES, INC. 214 CARNEGIE CENTER, SUITE 300 PRINCETON NJ 08540 0 0 0 1 See Remarks Stock Option (right to buy) 13.39 2014-02-14 4 A 0 5875 0 A 2014-02-14 2024-02-14 Common Stock 5875 0 D Stock Option (right to buy) 8.83 2015-02-12 4 A 0 6500 0 A 2015-02-12 2025-02-12 Common Stock 6500 0 D Stock Option (right to buy) 3.30 2016-03-02 4 A 0 12000 0 A 2016-03-02 2026-03-02 Common Stock 12000 0 D The options, granted pursuant to the issuer's equity incentive plan and which vested as to 25% on the grant date and as to an additional 25% for each of the following three years, vested on an accelerated basis. Any remaining equity awards previously reported that did not vest prior to July 31, 2016 were forfeited effective as of such date. The options were originally granted in consideration of the reporting person's past services to the issuer and without payment of cash consideration. Former Group President, Advanced Wound Care /s/ Barry J. Wolfenson 2016-08-02